login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
SOLID BIOSCIENCES INC (SLDB) Stock News
USA
- NASDAQ:SLDB -
US83422E2046
-
Common Stock
4.06
USD
-0.16 (-3.68%)
Last: 11/7/2025, 8:17:57 PM
4.14
USD
+0.08 (+1.97%)
After Hours:
11/7/2025, 8:17:57 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SLDB Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Solid Biosciences Inc.
Solid Biosciences Awarded Innovation Passport Designation Under the New UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy
4 days ago - By: Benzinga
- Mentions:
MYGN
SRPT
EVOK
TCMD
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
5 days ago - By: Solid Biosciences Inc.
Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
a month ago - By: Solid Biosciences Inc.
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
a month ago - By: Solid Biosciences Inc.
Solid Biosciences to Present at Upcoming Scientific Meetings
a month ago - By: Solid Biosciences Inc.
Solid Biosciences to Present at 2025 Neuromuscular Study Group Annual Scientific Meeting
2 months ago - By: Solid Biosciences Inc.
Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101
2 months ago - By: Solid Biosciences Inc.
Solid Biosciences to Participate at Upcoming Investor Conferences
3 months ago - By: Solid Biosciences Inc.
Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates
3 months ago - By: Solid Biosciences Inc.
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Yahoo Finance
- Mentions:
VOR
SRPT
Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board
4 months ago - By: Kaskela Law LLC
SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Solid Biosciences Inc. (NASDAQ: SLDB) and Encourages Long-Term SLDB Investors to Contact the Firm
4 months ago - By: Yahoo Finance
- Mentions:
VZ
Citi Initiates Coverage on Solid Biosciences Inc. (SLDB) with ‘Buy’ Rating and $14 PT
4 months ago - By: Stocktwits
Solid Biosciences Stock Pops On US, Canada Nod For Gene Therapy Trials: Retail Buzz Spikes
4 months ago - By: Solid Biosciences Inc.
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
4 months ago - By: Solid Biosciences Inc.
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: Yahoo Finance
- Mentions:
RY
RY.CA
RJF
WFC
...
General Mills upgraded, Trade Desk downgraded: Wall Street's top analyst calls
5 months ago - By: Benzinga
- Mentions:
SRPT
Analyst Downgrades Sarepta As Elevidys Safety Clouds Future Demand
5 months ago - By: Solid Biosciences Inc.
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6 months ago - By: Solid Biosciences Inc.
Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates
6 months ago - By: Solid Biosciences Inc.
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6 months ago - By: Solid Biosciences Inc.
Solid Biosciences to Participate at The Citizens Life Sciences Conference
6 months ago - By: Solid Biosciences Inc.
Solid Biosciences to Present at the American Society of Gene and Cell Therapy’s 28th Annual Meeting
7 months ago - By: Solid Biosciences Inc.
Solid Biosciences to Participate at Upcoming Investor Conferences
7 months ago - By: Solid Biosciences Inc.
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7 months ago - By: Climb Bio, Inc.
- Mentions:
CLYM
ABOS
LENZ
VERV
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
8 months ago - By: Solid Biosciences Inc.
Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
8 months ago - By: Solid Biosciences Inc.
Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
8 months ago - By: Solid Biosciences Inc.
Solid Biosciences to Participate at Upcoming Investor Conferences
8 months ago - By: Solid Biosciences Inc.
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Please enable JavaScript to continue using this application.